Medical Condition News

RSS

FDA approves IDE Supplement for third patient allotment in HeartWare Ventricular Assist System ADVANCE trial

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a third allotment, of 94 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).

25 Jan 2011

St. Georg Hospital performs two live procedures using Endoscopic Ablation System

CardioFocus announced that two "live cases" using its Endoscopic Ablation System were recently conducted. The first live case was a satellite transmission performed at Centro Cardiologico Monzino in Milan, Italy; broadcast to the 16th Annual Boston Symposium on Atrial Fibrillation in Boston, MA.

25 Jan 2011

Eisai's eritoran ACCESS study in severe sepsis does not meet primary endpoint

Based on the preliminary findings from the ACCESS (A Controlled Comparison of Eritoran and Placebo in Patients with Severe Sepsis) trial, Eisai Inc. announced today that the company will not submit marketing authorization applications to regulatory authorities in the United States, the European Union and Japan by the end of the fiscal year (March 31, 2011), as previously planned.

25 Jan 2011

LHSC performs complicated aortic valve bypass surgery using Correx AVB device

Doctors at London Health Sciences Centre (LHSC) are the first in the world to use a new implantable surgical device that promises to revolutionize aortic valve bypass surgery.

25 Jan 2011

Diamyd Medical to report European Phase III trial results for type 1 diabetes

Diamyd Medical's President and CEO Elisabeth Lindner states in the CEO comments in today's quarterly report that the Company expects to begin reporting the results from the European Phase III trial in type 1 diabetes as planned in late spring 2011.

25 Jan 2011

Patients with chronic depression can benefit from pioneering neurosurgical treatment

Pioneering neurosurgical treatment, a world first in Bristol, which very accurately targets brain networks involved in depression, could help people who suffer with severe and intractable depression.

25 Jan 2011

Researchers discover new treatment for difficult-to-control high blood pressure

Researchers were surprised to discover what may be a potential new treatment for difficult-to-control high blood pressure, according to a case report published in the January 25, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

25 Jan 2011

RRD enters partnership with NIH Therapeutics for Rare and Neglected Diseases program

RRD International, a strategy-driven biotech and pharmaceutical product development company, announced today that it has entered into a partnership with the National Institutes of Health (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program as a regulatory support and development partner.

25 Jan 2011

Promising results from TheraTears Nutrition pilot trial in dry eye patients

Advanced Vision Research, Inc. today announced the publication in the journal Cornea of promising results from a pilot trial of dry eye patients taking TheraTears® Nutrition. The study demonstrated a reduction in dry eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears® Nutrition, an optimized blend of medical grade essential omega-3 oils, including eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and flaxseed oil.

25 Jan 2011

Chiropractic treatment helps female Army Brigadier General to battle against fibromyalgia

After 27 years of service, decorated U.S. Army Brigadier General Becky Halstead (Retired), the first female West Point graduate in U.S. history to command at the strategic level in Iraq and Afghanistan, decided to retire after being diagnosed with fibromyalgia - a medically unexplained syndrome affecting the muscles and connective tissues.

25 Jan 2011

New study finds unrealistic optimism prevalent among participants in early-phase cancer trials

Can optimism be ethically problematic? Yes, according to a new study, which found unrealistic optimism prevalent among participants in early-phase cancer trials and suggested that it may compromise informed consent.

25 Jan 2011

p38-targeted compounds hold promise for Alzheimer's disease treatment

Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, has been awarded a $750,000 grant to further her research into a possible treatment for Alzheimer's disease. The grant is from the Edward N. And Della L. Thome Memorial Foundation, and was one of only eight Awards in Alzheimer's Disease Drug Discovery Research to be given in the U.S. in 2010.

25 Jan 2011

Researchers design engineered organ study the use of nanoparticles in breast cancer detection

Purdue University researchers have reproduced portions of the female breast in a tiny slide-sized model dubbed "breast on-a-chip" that will be used to test nanomedical approaches for the detection and treatment of breast cancer.

25 Jan 2011

SNM commends FDA Advisory Committee recommendation for florbetapir approval

The Society of Nuclear Medicine (SNM) commends the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir.

25 Jan 2011

TU Delft receives EU grant to diagnose and monitor Crohn's disease using MRI scans

Colonoscopy is the standard intestinal examination for diagnosing and monitoring Crohn's disease. It is a stressful procedure in which a flexible tube fitted with a camera is passed into the large intestine. MRI scans are therefore often used as an alternative to monitor the course of the disease and how it is responding to treatment.

25 Jan 2011

FDA approves Matrix's generic Protonix DR Tablets ANDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-release (DR) Tablets USP, 20 mg (base) and 40 mg (base), the generic version of Wyeth's Protonix® DR Tablets, a treatment for the irritation of the esophagus caused by gastroesophageal reflux disease (GERD).

25 Jan 2011

New investigative tool may explore intracellular processes with unprecedented clarity

Nongjian Tao and his colleagues at the Biodesign Institute at Arizona State University have pioneered a new technique capable of peering into single cells and even intracellular processes with unprecedented clarity.

25 Jan 2011

FDA grants pre-market clearance for SBi's rHead Extended Stem

Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.

From Evident Corporation - Life Sciences 24 Jan 2011

Bax factor that promotes cell death is also involved in regulating mitochondria behavior

New research led by UC Davis scientists provides insight into why some body organs are more susceptible to cell death than others and could eventually lead to advances in treating or preventing heart attack or stroke.

24 Jan 2011

UWE researcher receives two CSPCT grants to improve clinical delivery of treatments

A researcher from the University of the West of England has been awarded two grants to fund work that will encourage people with serious joint conditions to move and excercise more.

24 Jan 2011

Medical Condition News

FDA approves IDE Supplement for third patient allotment in HeartWare Ventricular Assist System ADVANCE trial

St. Georg Hospital performs two live procedures using Endoscopic Ablation System

Eisai's eritoran ACCESS study in severe sepsis does not meet primary endpoint

LHSC performs complicated aortic valve bypass surgery using Correx AVB device

Diamyd Medical to report European Phase III trial results for type 1 diabetes

Patients with chronic depression can benefit from pioneering neurosurgical treatment

Researchers discover new treatment for difficult-to-control high blood pressure

RRD enters partnership with NIH Therapeutics for Rare and Neglected Diseases program

Promising results from TheraTears Nutrition pilot trial in dry eye patients

Chiropractic treatment helps female Army Brigadier General to battle against fibromyalgia

New study finds unrealistic optimism prevalent among participants in early-phase cancer trials

p38-targeted compounds hold promise for Alzheimer's disease treatment

Researchers design engineered organ study the use of nanoparticles in breast cancer detection

SNM commends FDA Advisory Committee recommendation for florbetapir approval

TU Delft receives EU grant to diagnose and monitor Crohn's disease using MRI scans

FDA approves Matrix's generic Protonix DR Tablets ANDA

New investigative tool may explore intracellular processes with unprecedented clarity

FDA grants pre-market clearance for SBi's rHead Extended Stem

Bax factor that promotes cell death is also involved in regulating mitochondria behavior

UWE researcher receives two CSPCT grants to improve clinical delivery of treatments

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Latest News